Princeton, NJ (September 27, 2004) – In type 2 diabetes patients, use of NovoLog® Mix 70/30 FlexPen® (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]), a ...
FlexPen redesign launched Novo Nordisk has redesigned and launched the FlexPen for Levemir (insulin detemir [rDNA origin] injection), NovoLog (insulin aspart [recombinant] injection) and NovoLog Mix ...
A small number of batches of the insulin medication NovoMix 30 FlexPen and Penfill (Novo Nordisk) are to be recalled in the European Union, and the European Medicines Agency (EMA) is recommending that ...